4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-122887
Chairman & CEO bought 450 shares at an average $7.41 ($3,335)
From the SEC's structured data for this filing
Trades in this filing
BENTSUR RON · Chairman & CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-25 | Purchase : show line 1 in the form | +150 | $7.38 | $1,107 | 3,015,009 | D |
| 2022-11-28 | Purchase : show line 2 in the form | +150 | $7.40 | $1,110 | 3,015,159 | D |
| 2022-11-29 | Purchase : show line 3 in the form | +150 | $7.45 | $1,118 | 3,015,309 | D |
| Open-market purchases · 450 sh · avg $7.41 · $3,335 | ||||||
Loading xslF345X03/tm2231558-1_4seq1.xml…